McCarthy G M, Westfall P R, Masuda I, Christopherson P A, Cheung H S, Mitchell P G
Department of Clinical Pharmacology, The Royal College of Surgeons in Ireland, 123 St. Stephen's Green, Dublin 2, Ireland.
Ann Rheum Dis. 2001 Apr;60(4):399-406. doi: 10.1136/ard.60.4.399.
To determine the ability of basic calcium phosphate (BCP) crystals to induce (a) mitogenesis, matrix metalloproteinase (MMP)-1, and MMP-13 in human osteoarthritic synovial fibroblasts (HOAS) and (b) MMP-13 in cultured porcine articular chondrocytes.
Mitogenesis of HOAS was measured by [3H]thymidine incorporation assay and counts of cells in monolayer culture. MMP messenger RNA (mRNA) accumulation was determined either by northern blot analysis or reverse transcriptase-polymerase chain reaction (RT-PCR) of RNA from chondrocytes or HOAS treated with BCP crystals. MMP-13 secretion was identified by immunoprecipitation and MMP-1 secretion by western blot of conditioned media.
BCP crystals caused a 4.5-fold increase in [3H]thymidine incorporation by HOAS within 20 hours compared with untreated control cultures (p< or =0.05). BCP crystals induced MMP-13 mRNA accumulation and MMP-13 protein secretion by articular chondrocytes. In contrast, in HOAS, MMP-13 mRNA induced by BCP crystals was detectable only by RT-PCR, and MMP-13 protein was undetectable. BCP crystals induced MMP-1 mRNA accumulation and MMP-1 protein secretion by HOAS. MMP-1 expression was further augmented when HOAS were co-incubated with either BCP and tumour necrosis factor alpha (TNFalpha; threefold) or BCP and interleukin 1alpha (IL1alpha; twofold).
These data confirm the ability of BCP crystals to activate HOAS, leading to the induction of mitogenesis and MMP-1 production. MMP-13 production in response to BCP crystals is substantially more detectable in porcine articular chondrocytes than in HOAS. These data support the active role of BCP crystals in osteoarthritis and suggest that BCP crystals act synergistically with IL1alpha and TNFalpha to promote MMP production and subsequent joint degeneration.
确定碱性磷酸钙(BCP)晶体诱导(a)人骨关节炎滑膜成纤维细胞(HOAS)的有丝分裂、基质金属蛋白酶(MMP)-1和MMP-13以及(b)培养的猪关节软骨细胞中MMP-13的能力。
通过[3H]胸腺嘧啶核苷掺入试验和单层培养细胞计数来测量HOAS的有丝分裂。通过对用BCP晶体处理的软骨细胞或HOAS的RNA进行Northern印迹分析或逆转录聚合酶链反应(RT-PCR)来确定MMP信使核糖核酸(mRNA)的积累。通过免疫沉淀鉴定MMP-13的分泌,通过条件培养基的蛋白质印迹鉴定MMP-1的分泌。
与未处理的对照培养物相比,BCP晶体在20小时内使HOAS的[3H]胸腺嘧啶核苷掺入增加了4.5倍(p≤0.05)。BCP晶体诱导关节软骨细胞中MMP-13 mRNA的积累和MMP-13蛋白的分泌。相反,在HOAS中,仅通过RT-PCR可检测到BCP晶体诱导的MMP-13 mRNA,而未检测到MMP-13蛋白。BCP晶体诱导HOAS中MMP-1 mRNA的积累和MMP-1蛋白的分泌。当HOAS与BCP和肿瘤坏死因子α(TNFα;增加3倍)或BCP和白细胞介素1α(IL1α;增加2倍)共同孵育时,MMP-1的表达进一步增强。
这些数据证实了BCP晶体激活HOAS的能力,导致有丝分裂的诱导和MMP-1的产生。与HOAS相比,猪关节软骨细胞中对BCP晶体产生反应的MMP-13的产生更易于检测到。这些数据支持BCP晶体在骨关节炎中的积极作用,并表明BCP晶体与IL1α和TNFα协同作用以促进MMP的产生和随后的关节退变。